Nykode Therapeutics AS (VACBF) Q3 2024 Earnings

21AugConfirmed
Q4 2023
Q2 2024
Q3 2024
-0.05
-0.04
-0.03
-0.02

Details

Expected EPS
-0.049687
Actual EPS
-0.022747
Surprise EPS
0.03
Surprise Percent
+54.22%

Description

Nykode Therapeutics AS (VACBF) has reported earnings of -0.022747 per share for Q3 2024.

0 Comments

Share your thoughts